Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer
Status:
Terminated
Trial end date:
2021-08-26
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies how well ferumoxytol-enhanced magnetic resonance imaging
(MRI) works in imaging lymph nodes in patients with rectal cancer that has spread from where
it started to nearby tissue or lymph nodes (locally advanced). Ferumoxytol is a form of very
small iron particles that are taken up by cells in normal lymph nodes and may work better in
imaging patients with rectal cancer when given with MRI.
Phase:
Early Phase 1
Details
Lead Sponsor:
OHSU Knight Cancer Institute
Collaborators:
National Cancer Institute (NCI) Oregon Health and Science University Radiological Society of North America